Beyond Bone Marrow: Early Detection of Multiple Myeloma Progression with Peripheral Residual Disease
We invite you to a special webinar with Dr. Bruno Paiva, an internationally recognized myeloma researcher, to learn about new and less invasive ways of keeping track of myeloma. By studying the blood instead of relying only on bone marrow tests, doctors may be able to follow the disease more comfortably and identify changes sooner. Dr. Paiva will explain how this research could improve quality of life for patients and help guide care in the years ahead.
Cynthia introduces the agenda of the event and featured speaker Bruno Paiva, PharmD, PhD
Dr. Paiva talks about early detection of progression
Type your questions in the chat and we will answer them!
Cynthia Cahoon, RN
Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.
Bruno Paiva, PharmD, PhD
Bruno Paiva is Director of the Flow Cytometry Platform and Director of the Monoclonal Gammopathies Research Laboratory, both at the centre for applied medical research (CIMA) University of Navarra, Pamplona, Spain, where he is also a research fellow of the Department of Haematology. He gained his Doctor of Pharmacy degree in in 2007 from the University of Coimbra, Portugal, and his PhD at the Medical School of the University of Salamanca, Spain. Dr Paiva’s main area of expertise is the multidimensional flow cytometry analysis of haematological malignancies. His research focuses on immunogenomics to improve differential diagnosis, risk stratification, and monitoring of patients with monoclonal gammopathies and myeloid malignancies. Dr Paiva’s flow cytometry core is the referral laboratory for numerous Hospitals and has been the core of more than 30 national and international clinical trials in multiple myeloma and acute myeloid leukaemia. Throughout his 17-year-long research career, Dr Paiva has authored or co-authored more than 200 publications, including more than 40 publications in the most prestigious journal in the haematology sector: Blood. Dr Paiva received numerous awards including the Bart Barlogie Young Investigator Award for outstanding research developed in multiple myeloma in 2015, the Brian G.M. Durie Outstanding Achievement Award by the International Myeloma Foundation (IMF) for his contribution to improving the lives of patients with myeloma in 2022, and the Joseph Michaeli award for outstanding contributions to myeloma in 2024.